Covid-19 Spreads into the World of Oncology

Takeda has added a Covid-19 Expansion arm to their phase 1 trial exploring the small molecule TAK-981 in solid tumors and hematologic malignancies. As this pandemic continues, we will likely see increased numbers of oncology clinical trials modifying procedures to treat patients with Covid-19.

See our study design schema below for trial further details about this trial.